(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) Á¦73ȸ ´ëÇÑ»ý¸®ÇÐȸ Çмú´ëȸ (1ÀÏÂ÷) : 2021-10-27±³À°ÀÏÀÚ : 2021-10-27
±³À°Àå¼Ò : ¿Â-¿ÀÇÁ¶óÀÎ º´Çà (¿¬¼¼´ëÇб³ ¹é¾ç´©¸® ±¹Á¦È¸ÀǽÇ(IBK±â¾÷ÀºÇàȦ ¿Ü 2°³·ë))
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) Á¦73ȸ ´ëÇÑ»ý¸®ÇÐȸ Çмú´ëȸ (1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ»ý¸®ÇÐȸ
´ã´çÀÚ : ¹Ú±Ô»ó
¿¬¶ôó : 033-741-0294
À̸ÞÀÏ :
qsang@yonsei.ac.kr ±³À°Á¾·ù : »ý¸®ÇÐ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 400,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 09:30~10:00 Discovery of neuropeptides in human serum samples associated with addiction ÀÌÁöÀº(KIST)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 10:00~10:30 Anxiolytic role of CART peptide in depression À±Çü½Å(¿¬¼¼´ë)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 10:30~11:15 Ghrelin in Alzheimer ¹®¹ÎÈ£(°Ç¾ç´ë)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 11:15~12:00 Food restriction, ghrelin, and amphetamine ±èÁ¤ÈÆ(¿¬¼¼ÀÇ´ë)
½Ä»ç 10-27 12:00~13:00 ½Ä»ç ()
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 13:00~13:40 Physiological roles of CALHM1/3 channels Akiyuki Taruno(Kyoto Prefectual Univ)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 13:40~14:15 Biophysical regulation and molecular structural understanding of CALHM channel activation ±è¼ºÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 14:15~15:00 ATP release via connexin channels in atrial myocytes under mechanical stress ¿ì¼±Èñ(Ãæ³²´ë)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® IBK±â¾÷ÀºÇà Ȧ 15:00~15:30 Physiological Roles of ANO9 Channel ¿À¿ìÅÃ(KIST)
Åä·Ð 10-27 15:30~15:50 Æ÷½ºÅÍ ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® °ûÁ¤È¯È¦ 15:50~16:20 Elucidate novel genetics and pathobiology of hearing loss ÁöÇ念(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® °ûÁ¤È¯È¦ 16:20~16:50 A nonsense TMEM43 variant leads to disruption of connexin-linked function and autosomal dominant auditory neuropathy spectrum disorder ÀÌâÁØ(IBS)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® °ûÁ¤È¯È¦ 16:50~17:20 Cholesterol metabolite mediated hearing loss in Pex5 cKO mice ¹Ú·¡±æ(GIST)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® °ûÁ¤È¯È¦ 17:20~17:50 Gene therapy of sensorineural hearing loss using adeno-associated virus in mouse model ±è¾ð°æ(°æºÏ´ëÇб³)
±³À°½Ã°£ 10-27 ¿¬¼¼´ëÇб³ ¹é¾ç´©¸® °ûÁ¤È¯È¦ 17:50~18:20 Editing a channelopathy in hearing loss Á¤Áø¼¼(¿¬¼¼ÀÇ´ë)